VAERS reports by lot

GSK Hepatitis A lot G99R4: VAERS reports

31 VAERS reports list lot G99R4 as a GSK Hepatitis A vaccine, received between 2020-01-24 and 2022-10-15. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction429%
Neurological321%
Allergic / Anaphylactic321%
Gastrointestinal214%
Musculoskeletal17%
Dermatological (non-injection-site)17%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Michigan6
Tennessee4
Georgia3
Iowa2
Missouri2
Texas2
Pennsylvania1
Ohio1
Kansas1
Wisconsin1
West Virginia1
Utah1

Reports by month received

MonthReportsBar
2020-012
2020-031
2020-091
2020-111
2021-041
2021-052
2021-071
2021-083
2021-114
2021-122
2022-011
2022-043
2022-066
2022-071
2022-081
2022-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis A lots (A–Z): FB3A3 · FB9RH · G79C4 · GR55T · H4H53 · HR4RB

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.